Skip to main content

Market Overview

12 Health Care Stocks Moving In Tuesday's Intraday Session

Share:
12 Health Care Stocks Moving In Tuesday's Intraday Session

 

Gainers

  • Triple-S Management (NYSE:GTS) shares moved upwards by 45.3% to $35.15 during Tuesday's regular session. As of 12:30 EST, Triple-S Management's stock is trading at a volume of 3.7 million, which is 7057.79% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $836.4 million.
  • Reviva Pharmaceuticals (NASDAQ:RVPH) shares moved upwards by 16.62% to $3.93. As of 12:30 EST, this security is trading at a volume of 2.3 million shares, making up 2066.86% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $52.6 million.
  • Baudax Bio (NASDAQ:BXRX) shares rose 15.99% to $0.61. As of 12:30 EST, Baudax Bio's stock is trading at a volume of 36.1 million, which is 1573.04% of its average full-day volume over the last 100 days. The company's market cap stands at $51.3 million.
  • Bio-Path Holdings (NASDAQ:BPTH) stock increased by 15.46% to $6.57. As of 12:30 EST, this security is trading at a volume of 58.7 million shares, making up 28637.33% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $45.7 million.
  • GT Biopharma (NASDAQ:GTBP) shares increased by 15.38% to $8.43. Trading volume for this security as of 12:30 EST is 426.7K, which is 126.77% of its average full-day volume over the last 100 days. The company's market cap stands at $178.2 million. As per the press release, Q2 earnings came out yesterday.
  • XTL Biopharmaceuticals (NASDAQ:XTLB) shares rose 13.73% to $4.72. The current volume of 164.9K shares is 125.62% of XTL Biopharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $24.9 million.

 

 

Losers

 

  • Theravance Biopharma (NASDAQ:TBPH) shares declined by 31.83% to $9.66 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 6.2 million, which is 1461.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $709.7 million.
  • Vivos Therapeutics (NASDAQ:VVOS) shares fell 14.5% to $5.04. As of 12:30 EST, this security is trading at a volume of 6.0 million shares, making up 200.08% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $115.0 million.
  • ImmuCell (NASDAQ:ICCC) shares fell 11.95% to $8.0. Trading volume for ImmuCell's stock is 52.5K as of 12:30 EST. This is 405.0% of its average full-day volume over the last 100 days. The company's market cap stands at $61.9 million.
  • Generation Bio (NASDAQ:GBIO) stock declined by 10.33% to $22.75. Trading volume for this security as of 12:30 EST is 235.4K, which is 70.04% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 billion.
  • PolarityTE (NASDAQ:PTE) shares decreased by 10.26% to $0.75. PolarityTE's stock is trading at a volume of 4.3 million shares as of 12:30 EST. This is 375.37% of its average full-day volume over the last 100 days. The company's market cap stands at $61.1 million.
  • Evaxion Biotech (NASDAQ:EVAX) shares decreased by 9.41% to $5.3. The market value of their outstanding shares is at $101.7 million.

 

 

 

Related Articles (BPTH + BXRX)

View Comments and Join the Discussion!

Posted-In: BZI-TFMIntraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com